{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:58:08Z","timestamp":1783641488438,"version":"3.55.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.transci.2022.103372","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T16:27:34Z","timestamp":1642868854000},"page":"103372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5917-8071","authenticated-orcid":false,"given":"Hasan Atilla","family":"\u00d6zkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0131d\u0131ka G\u00fclkan","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2022.103372_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.transci.2022.103372_bib0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.transci.2022.103372_bib0015","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms","volume":"19","author":"Shulman","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.transci.2022.103372_bib0020","first-page":"885","article-title":"Senecio poisoning exhibiting as Chiari\u2019s syndrome; a report on twelve cases","volume":"27","author":"Selzer","year":"1951","journal-title":"Am J Pathol"},{"key":"10.1016\/j.transci.2022.103372_bib0025","first-page":"5","article-title":"Fatal veno-occlusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory acute leukaemia","volume":"55","author":"Jacobs","year":"1979","journal-title":"S Afr Med J"},{"key":"10.1016\/j.transci.2022.103372_bib0030","series-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation","first-page":"906","author":"Mohty","year":"2016"},{"key":"10.1016\/j.transci.2022.103372_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0040","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.transci.2022.103372_bib0045","series-title":"Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study","first-page":"2474","author":"Kantarjian","year":"2019"},{"key":"10.1016\/j.transci.2022.103372_bib0050","series-title":"Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","first-page":"816","author":"Kernan","year":"2018"},{"key":"10.1016\/j.transci.2022.103372_bib0055","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/MEG.0000000000001802","article-title":"Hepatic veno-occlusive disease development in the hematopoietic stem cell transplantation patients: incidence and associated risk factors, a meta-analysis","volume":"33","author":"Xia","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.transci.2022.103372_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00489","article-title":"Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Bonifazi","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2022.103372_bib0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0070","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2022.103372_bib0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbmt.2018.07.039","article-title":"Early clinical predictors of hepatic veno-occlusive Disease\/Sinusoidal obstruction syndrome after myeloablative stem cell transplantation","volume":"25","author":"Roeker","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0080","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/bmt.2014.168","article-title":"Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen","volume":"49","author":"Tsirigotis","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0085","series-title":"CD33 expression and Gentuzumab Ozogamicin in acute myeloid leukemia: two sides of the same coin","author":"Molica","year":"2021"},{"key":"10.1016\/j.transci.2022.103372_bib0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13045-020-00975-2","article-title":"Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia","volume":"13","author":"Cortes","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.transci.2022.103372_bib0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","article-title":"Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease","volume":"40","author":"Dignan","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2022.103372_bib0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000028359","article-title":"Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes","volume":"60","author":"DeLeve","year":"2000","journal-title":"Pharmacology"},{"key":"10.1016\/j.transci.2022.103372_bib0110","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103372_bib0115","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade","volume":"17","author":"Carreras","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0120","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.16557","article-title":"Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS\/VOD after haematopoietic cell transplantation","volume":"190","author":"Cairo","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2022.103372_bib0125","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.transci.2022.103372_bib0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","article-title":"The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Cooke","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0135","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation","volume":"89","author":"Salat","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103372_bib0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41409-019-0705-z","article-title":"Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a position statement from an international expert group","volume":"55","author":"Mohty","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbmt.2019.10.024","article-title":"Incidence, predictors, and outcomes of veno-occlusive Disease\/Sinusoidal obstruction syndrome after reduced-intensity allogeneic hematopoietic cell transplantation","volume":"26","author":"Lewis","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0150","series-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","first-page":"781","author":"Mohty","year":"2015"},{"key":"10.1016\/j.transci.2022.103372_bib0155","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/bmt.2016.237","article-title":"Diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome of the liver: problems of interpretation","volume":"51","author":"Volin","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0160","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bbmt.2020.03.011","article-title":"Incidence of anicteric veno-occlusive Disease\/Sinusoidal obstruction syndrome and outcomes with defibrotide following hematopoietic cell transplantation in adult and pediatric patients","volume":"26","author":"Corbacioglu","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0165","series-title":"Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review","first-page":"463","author":"Ravaioli","year":"2019"},{"key":"10.1016\/j.transci.2022.103372_bib0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1148\/radiology.204.2.9240551","article-title":"Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients","volume":"204","author":"Lassau","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.transci.2022.103372_bib0175","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.bbmt.2018.05.025","article-title":"Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation","volume":"24","author":"Nishida","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002470000373","article-title":"Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings","volume":"31","author":"McCarville","year":"2001","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.transci.2022.103372_bib0185","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3348\/kjr.2014.15.2.218","article-title":"Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features","volume":"15","author":"Zhou","year":"2014","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.transci.2022.103372_bib0190","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1590\/1414-431x20154563","article-title":"Computed tomography findings of hepatic veno-occlusive disease caused by Sedum aizoon with histopathological correlation","volume":"48","author":"Shao","year":"2015","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.transci.2022.103372_bib0195","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2214\/AJR.05.0539","article-title":"CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation","volume":"186","author":"Erturk","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.transci.2022.103372_bib0200","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.acra.2017.10.012","article-title":"CT features of hepatic veno-occlusive disease: a meta-analysis","volume":"25","author":"Yang","year":"2018","journal-title":"Acad Radiol"},{"key":"10.1016\/j.transci.2022.103372_bib0205","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s003300000330","article-title":"Imaging findings in two patients with hepatic veno-occlusive disease following bone marrow transplantation","volume":"10","author":"van den Bosch","year":"2000","journal-title":"Eur Radiol"},{"key":"10.1016\/j.transci.2022.103372_bib0210","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00330-011-2333-x","article-title":"Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases","volume":"22","author":"Shin","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.transci.2022.103372_bib0215","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.bbmt.2020.06.016","article-title":"Imaging in hepatic veno-occlusive Disease\/Sinusoidal obstruction syndrome","volume":"26","author":"Chan","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0220","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbmt.2019.01.019","article-title":"Liver stiffness measurement allows early diagnosis of veno-occlusive Disease\/Sinusoidal obstruction syndrome in adult patients who undergo hematopoietic stem cell transplantation: results from a monocentric prospective study","volume":"25","author":"Colecchia","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0225","article-title":"Longitudinal evaluation of liver stiffness in three pediatric patients with veno-occlusive disease","volume":"23","author":"Zama","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.transci.2022.103372_bib0230","series-title":"Shear wave elastography in the detection of sinusoidal obstruction syndrome in adult patients undergoing allogenic hematopoietic stem cell transplantation","author":"Schulz","year":"2021"},{"key":"10.1016\/j.transci.2022.103372_bib0235","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3324\/haematol.2019.245407","article-title":"Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation","volume":"106","author":"Debureaux","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2022.103372_bib0240","author":"Ravaioli","year":"2020"},{"key":"10.1016\/j.transci.2022.103372_bib0245","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk factors for development of and progression of hepatic veno-occlusive Disease\/Sinusoidal obstruction syndrome","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0250","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","article-title":"Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation","volume":"21","author":"Akil","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0255","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transci.2022.103372_bib0260","series-title":"Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome\/veno-occlusive disease (SOS\/VOD).","first-page":"1361","author":"Yoon","year":"2019"},{"key":"10.1016\/j.transci.2022.103372_bib0265","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41409-019-0705-z","article-title":"Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a position statement from an international expert group","volume":"55","author":"Mohty","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0270","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the european group for blood and marrow transplantation","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103372_bib0275","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification","volume":"22","author":"Dalle","year":"2016","journal-title":"Prophylaxis, and Treatment. Biology of blood and marrow transplantation\u202f: journal of the American Society for Blood and Marrow Transplantation."},{"key":"10.1016\/j.transci.2022.103372_bib0280","series-title":"Incidence and risk factors of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation in adults with prophylactic ursodiol and intravenous heparin or prostaglandin E1","first-page":"1603","author":"Yoon","year":"2021"},{"key":"10.1016\/j.transci.2022.103372_bib0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10428194.2015.1041387","article-title":"High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma","volume":"57","author":"Hwang","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2022.103372_bib0290","article-title":"Management of hepatic sinusoidal obstruction syndrome following treatment with gemtuzumab ozogamicin (Mylotarg)","volume":"2","author":"McDonald","year":"2002","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.transci.2022.103372_bib0295","series-title":"Analysis of risk factors for hepatic sinusoidal obstruction syndrome following allogeneic hematopoietic stem cell transplantation in pediatric patients","author":"Kloehn","year":"2021"},{"key":"10.1016\/j.transci.2022.103372_bib0300","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.bbmt.2018.06.013","article-title":"Risk score for the development of veno-occlusive disease after allogeneic hematopoietic cell transplant","volume":"24","author":"Strouse","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0305","doi-asserted-by":"crossref","DOI":"10.4274\/tjh.galenos.2021.2021.0174","article-title":"Pre-conditioning serum uric acid as a risk factor for sinusoidal obstruction syndrome of the liver in children undergoing hematopoietic stem cell transplantation","author":"Visal Okur","year":"2021","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.transci.2022.103372_bib0310","series-title":"Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma","first-page":"531","author":"Schechter","year":"2020"},{"key":"10.1016\/j.transci.2022.103372_bib0315","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12185-014-1578-y","article-title":"Experience from a single paediatric transplant centre with identification of some protective and risk factors concerning the development of hepatic veno-occlusive disease in children after allogeneic hematopoietic stem cell transplant","volume":"99","author":"Maximova","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.transci.2022.103372_bib0320","unstructured":"https:\/\/www.cibmtr.org\/ReferenceCenter\/Statistical\/Tools\/Pages\/VOD.aspx#:\u223c:text=%E2%80%8BVeno%2Docclusive%20disease%20of,%2Docclusive%20disease%20(VOD)."},{"key":"10.1016\/j.transci.2022.103372_bib0325","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/bbmt.2002.v8.pm12374454","volume":"8","author":"Kashyap","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0330","first-page":"439","article-title":"A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation","volume":"10","author":"Blostein","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0335","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/bmt.2015.283","article-title":"Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes","volume":"51","author":"Yakushijin","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0340","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/ehm.12.18","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"5","author":"Corbacioglu","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.transci.2022.103372_bib0345","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbmt.2018.09.027","article-title":"Sinusoidal obstruction Syndrome\/Veno-Occlusive disease after autologous or allogeneic hematopoietic stem cell transplantation in children: a retrospective study of the italian hematology-oncology association-hematopoietic stem cell transplantation group","volume":"25","author":"Faraci","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0350","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hon.2789","article-title":"Targeted-dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 \u03bcMol\u2e31min. A historically controlled clinical trial","volume":"38","author":"Esteves","year":"2020","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.transci.2022.103372_bib0355","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12185-020-02891-0","article-title":"Busulfan clearance does not predict the development of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation","volume":"112","author":"Salman","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.transci.2022.103372_bib0360","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbmt.2007.06.005","article-title":"Randomized comparison of four-times-daily versus once-daily intravenous busulfan in conditioning therapy for hematopoietic cell transplantation","volume":"13","author":"Ryu","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0365","series-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","first-page":"344","author":"Gyurkocza","year":"2014"},{"key":"10.1016\/j.transci.2022.103372_bib0370","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders&#x2019","volume":"35","author":"Lazaridis","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.transci.2022.103372_bib0375","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0380","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbmt.2013.10.014","article-title":"Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study","volume":"20","author":"Ruutu","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0385","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/oli.2006.16.105","article-title":"Defibrotide, a polydisperse mixture of single-stranded phosphodiester oligonucleotides with lifesaving activity in severe hepatic veno-occlusive disease: clinical outcomes and potential mechanisms of action","volume":"16","author":"Noah Kornblum","year":"2006","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.transci.2022.103372_bib0390","doi-asserted-by":"crossref","first-page":"36","DOI":"10.12659\/AOT.883811","article-title":"Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation","volume":"18","author":"Park","year":"2013","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0395","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bbmt.2018.02.015","article-title":"Defibrotide for sinusoidal obstruction Syndrome\/Veno-Occlusive disease prophylaxis in high-risk adult patients: a single-center experience study","volume":"24","author":"Picod","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0400","unstructured":"Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02851407."},{"key":"10.1016\/j.transci.2022.103372_bib0405","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103372_bib0410","first-page":"185","article-title":"Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation","volume":"18","author":"Rosenthal","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0415","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1702854","article-title":"Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin","volume":"27","author":"Simon","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0420","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","article-title":"Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"37","author":"Imran","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0425","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","article-title":"A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation","volume":"84","author":"Bearman","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2022.103372_bib0430","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.1991.tb04402.x","article-title":"Prostaglandin E1 (PGE1) induced arthritis following bone marrow transplantation","volume":"78","author":"Bordigoni","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2022.103372_bib0435","first-page":"795","article-title":"Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III\/defibrotide therapy","volume":"91","author":"Haussmann","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2022.103372_bib0440","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.V82.3.732.732","article-title":"Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial","volume":"82","author":"Attal","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103372_bib0445","series-title":"Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation. The Cochrane database of systematic reviews","author":"Cheuk","year":"2015"},{"key":"10.1016\/j.transci.2022.103372_bib0450","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.bmt.1705724","article-title":"Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels","volume":"40","author":"Matsumoto","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0455","unstructured":"Defitelio (defibrotide sodium). https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/defitelio-defibrotide-sodium."},{"key":"10.1016\/j.transci.2022.103372_bib0460","unstructured":"Defitelio (Defibrotide) https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/defitelio."},{"key":"10.1016\/j.transci.2022.103372_bib0465","first-page":"737","article-title":"Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population","volume":"92","author":"Richardson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103372_bib0470","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103372_bib0475","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103372_bib0480","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.bbmt.2016.07.001","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the international compassionate-use program","volume":"22","author":"Corbacioglu","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0485","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbmt.2017.03.008","article-title":"Defibrotide for patients with hepatic veno-occlusive Disease\/Sinusoidal obstruction syndrome: interim results from a treatment IND study","volume":"23","author":"Richardson","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0490","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bbmt.2016.04.011","article-title":"Defibrotide for treatment of severe veno-occlusive disease in pediatrics and adults: an exploratory analysis using data from the center for international blood and marrow transplant research","volume":"22","author":"Strouse","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2020.09.008","article-title":"Analysis of time to complete response after defibrotide initiation in patients with hepatic veno-occlusive Disease\/Sinusoidal obstruction syndrome after hematopoietic cell transplantation","volume":"27","author":"Richardson","year":"2021","journal-title":"Transplantation and Cellular Therapy."},{"key":"10.1016\/j.transci.2022.103372_bib0500","series-title":"A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease\/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study","first-page":"2454","author":"Mohty","year":"2021"},{"key":"10.1016\/j.transci.2022.103372_bib0505","series-title":"Earlier defibrotide initiation post-diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation","first-page":"112","author":"Richardson","year":"2017"},{"key":"10.1016\/j.transci.2022.103372_bib0510","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1078155215591387","article-title":"Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a review of the literature","volume":"22","author":"Hopps","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.transci.2022.103372_bib0515","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1702209","article-title":"Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?","volume":"25","author":"Khoury","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0520","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1705201","article-title":"Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity?","volume":"37","author":"Hennenfent","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0525","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bmt.1705896","article-title":"Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone","volume":"41","author":"Al Beihany","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0530","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbmt.2012.11.011","article-title":"High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients","volume":"19","author":"Myers","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0535","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41409-018-0087-7","article-title":"High-dose methylprednisolone for the treatment of sinusoidal obstruction syndrome in adults","volume":"53","author":"Vaisvilas","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0540","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/sj.bmt.1702069","article-title":"Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation","volume":"24","author":"Schriber","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0545","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","article-title":"Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients","volume":"89","author":"Bearman","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103372_bib0550","first-page":"760","article-title":"Successful treatment of veno-occlusive disease of the liver with urokinase in a patient with non-Hodgkin\u2019s lymphoma","volume":"7","author":"Fogteloo","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.transci.2022.103372_bib0555","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/bmt.2013.101","article-title":"Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?","volume":"48","author":"Yoon","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0560","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.bmt.1705969","article-title":"A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Barkholt","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2022.103372_bib0565","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bcp.12789","article-title":"Evidence for the changing regimens of acetylcysteine","volume":"81","author":"Chiew","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transci.2022.103372_bib0570","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27518","article-title":"Treatment of hepatic veno-occlusive disease in children with N-acetylcysteine","author":"Lee","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2022.103372_bib0575","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.13215","article-title":"How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation","volume":"168","author":"Carreras","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2022.103372_bib0580","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","article-title":"Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation","volume":"11","author":"Bearman","year":"1993","journal-title":"J Clin Oncol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T16:26:22Z","timestamp":1741623982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050222000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1473050222000222"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2022.103372","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2022.103372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103372"}}